M R21 Pill - white round
Pill with imprint M R21 is White, Round and has been identified as Repaglinide 0.5 mg. It is supplied by Mylan Pharmaceuticals Inc.
Repaglinide is used in the treatment of Type 2 Diabetes and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Repaglinide 0.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M R21
Repaglinide
- Imprint
- M R21
- Strength
- 0.5 mg
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Meglitinides
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
butylated hydroxyanisole,
silicon dioxide,
corn starch,
croscarmellose sodium,
calcium phosphate dibasic anhydrous,
magnesium stearate,
meglumine,
microcrystalline cellulose,
polacrilin potassium,
sodium lauryl sulfate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00378-3121 (Discontinued) | Mylan Pharmaceuticals Inc. |
| 51079-0062 (Discontinued) | UDL Laboratories Inc. |
Related images for "M R21"
More about repaglinide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (12)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: meglitinides
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.